We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lilly Pulls Plug on Once-Promising Heart Drug Due to Lack of Efficacy
Lilly Pulls Plug on Once-Promising Heart Drug Due to Lack of Efficacy
Eli Lilly is suspending development of its leading heart drug candidate evacetrapib after an independent data monitoring committee determined it wasn’t effective in a Phase 3 clinical trial.